Controlled clinical trials with fenretinide in breast cancer, basal cell carcinoma and oral leukoplakia

We are conducting three randomized studies (breast cancer, basal cell carcinoma, oral leukoplakia) and report our methodological approach and accrual here. The aim of the breast cancer study is prevention of a contralateral primary lesion in women already treated for breast cancer; the aim of the ba...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of cellular biochemistry 1995, Vol.59 (S22), p.11-17
Hauptverfasser:	De Palo, Giuseppe, Veronesi, Umberto, Marubini, Ettore, Camerini, Tiziana, Chiesa, Fausto, Nava, Maurizio, Formelli, Franca, Del Vecchio, Marcella, Costa, Alberto, Boracchi, Patrizia, Mariani, Luigi
Format:	Artikel
Sprache:	eng
Schlagworte:	4-HPR Anticarcinogenic Agents - therapeutic use Breast Neoplasms - drug therapy Carcinoma, Basal Cell - prevention & control chemoprevention Female fenretinide Fenretinide - therapeutic use Humans Leukoplakia, Oral - prevention & control Skin Neoplasms - prevention & control
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!